Patiromer

Advertisement
Victoria SochaHyperkalemia | February 5, 2024
Among patients with end-stage kidney disease (ESKD) on dialysis, hyperkalemia is a common, potentially life-threatening ...
Victoria SochaHyperkalemia | February 5, 2024
The gold standard therapy for patients with heart failure with reduced ejection fraction (HFrEF) and chronic kidney ...
Victoria SochaHyperkalemia | February 5, 2024
Treatment for heart failure with reduced ejection fraction HFrEF) and chronic kidney disease includes use of ...
Victoria SochaHyperkalemia | February 5, 2024
The potassium binder patiromer has a favorable safety profile when compared with sodium polystyrene (SPS). Yoshitsugu ...
Victoria SochaHyperkalemia | February 5, 2024
Patients with chronic kidney disease (CKD) who experience hyperkalemia are at increased risk for morbidity and ...
Victoria SochaHyperkalemia | February 5, 2024
Hospitalized patients often develop hyperkalemia, a common electrolyte disorder. However, according to Katherine E. Di ...
Victoria SochaHyperkalemia | July 19, 2021
Patiromer (Veltassa®; Vifor Phrma, Inc.), a sodium-free potassium binder, is used for the management of hyperkalemia in ...
Victoria SochaHyperkalemia | September 30, 2020
Hyperkalemia (serum potassium level >5.0 mEq/L) is associated with cardiac dysrhythmias, sudden cardiac death, and ...
Victoria SochaHyperkalemia | October 14, 2020
In the United States, the overall prevalence of end-stage kidney disease (ESKD) is increasing; in 2016 there were ...
Victoria SochaChronic Kidney Disease | April 11, 2023
Spironolactone is known to be effective in reducing blood pressure in patients with resistant hypertension; however, the ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Patiromer, a sodium-free potassium binder approved for treating hyperkalemia in adults is not currently approved for use ...
Victoria SochaHyperkalemia | April 7, 2023
Patiromer, a sodium-free, nonabsorbed potassium binder is approved for the treatment of hyperkalemia. Results from the ...
Victoria SochaASN Kidney Week 2019 | April 7, 2023
Washington, DC—Researchers, led by Matthew Weir, MD,  conducted a post hoc analysis to examine the efficacy and ...
Victoria SochaHyperkalemia | April 7, 2023
Washington, DC—Patiromer, a sodium-free, nonabsorbed potassium binder is approved for the treatment of hyperkalemia. ...
DocWire News EditorsChronic Kidney Disease | April 11, 2023
An oral potassium binding polymer (patiromer) aided in the use of spironolactone in a subset of patients with heart ...
Victoria SochaHyperkalemia | April 7, 2023
Csaba P. Kovesdy, MD, and colleagues recently conducted a retrospective cohort study to examine the incidence of ...
Victoria SochaHyperkalemia | April 7, 2023
The novel sodium-free, non-absorbed potassium binder patiromer is approved for the treatment of hyperkalemia. Elvira O. ...
Advertisement